Valuation — not yet established
No valuation for VasoRx is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($32.7M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for VasoRx
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2019 | Seed Round | $3.1M | ▮ | ▮ |
| Apr 2018 | Debt | $1.6M | ▮ | ▮ |
How VasoRx's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For VasoRx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has VasoRx raised?
- VasoRx has raised $32.7M in total funding across 2 recorded rounds.
- When did VasoRx last raise?
- VasoRx last raised in Jan 2019 (Seed Round), raising $3.1M.